Tag: FDA biosimilars
Lot-to-Lot Variability in Biologics and Biosimilars: Why It Matters for Patients and Doctors
Lot-to-lot variability is a natural part of biologics and biosimilars due to their complex biological production. Unlike generics, these drugs aren't identical from batch to batch - but they're tightly controlled to ensure safety and effectiveness for patients.
Learn more...